+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Continuous Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Continuous Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 217 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6040796
Description Jump to:
The global continuous glucose monitoring (CGM) systems market is set to witness significant growth in the coming years, driven by technological advancements and increasing diabetes prevalence. Forecasted to expand at a robust CAGR of 9.3%, the market is projected to achieve a valuation of $13.14 billion by 2025 and $24.49 billion by 2032. CGM systems have revolutionized diabetes management, offering real-time insights into glucose fluctuations and enabling proactive care.

Market Insights

Continuous glucose monitoring systems utilize advanced sensors to provide accurate, real-time glucose data without the need for frequent finger stick tests. This innovative approach has enhanced the ability of patients and healthcare providers to manage diabetes effectively. The adoption of these systems is being propelled by growing awareness of their benefits, improved glycemic control capabilities, and convenience in diabetes management. The integration of CGM systems with digital health ecosystems has further amplified their demand.

The continuous glucose monitoring systems market is poised for transformative growth, with significant opportunities emerging in digital health integration, personalized medicine, and expanding regional markets. Technological advancements and supportive healthcare policies will continue to shape the trajectory of the market, driving innovation and ensuring broader access to effective diabetes management solutions.

Key Market Drivers

  • Technological Advancements: Continuous innovation in sensor technology has enhanced the accuracy, reliability, and user-friendliness of CGM systems. Improved data analytics capabilities, powered by artificial intelligence and machine learning, provide actionable insights for better diabetes management.
  • Increasing Diabetes Prevalence: A rise in sedentary lifestyles and unhealthy dietary habits has escalated diabetes cases globally, creating a pressing need for effective glucose monitoring solutions.
  • Favorable Government Policies: Comprehensive reimbursement initiatives and supportive regulatory frameworks in regions like North America have encouraged the adoption of CGM devices.

Business Opportunities

  • Integration with Digital Health Platforms: CGM devices are increasingly being integrated with health apps, electronic health records (EHRs), and telehealth services, enabling comprehensive diabetes care and personalized interventions.
  • Emerging Markets in Asia Pacific: The rapidly growing diabetic population and healthcare infrastructure advancements in Asia Pacific present lucrative opportunities for CGM device manufacturers.
  • Expansion of Home Care Diagnostics: With a growing preference for decentralized healthcare, home care diagnostics is becoming a key segment, offering convenience and real-time glucose monitoring.

Regional Analysis

  • North America: The region dominates the global CGM market, supported by robust healthcare infrastructure, high diabetes prevalence, and significant investments in research and development. Favorable reimbursement policies further boost market growth.
  • Asia Pacific: Expected to register the fastest CAGR through 2032, the region’s market growth is driven by an expanding diabetic population and increased adoption of advanced healthcare technologies in countries like China and India.
  • Europe: The market benefits from supportive government policies and rising awareness of advanced diabetes management solutions among healthcare providers and patients.

Key Players in the Market

Leading companies are implementing strategies to strengthen their market position:

  • Dexcom: Known for its advancements in sensor technology, offering devices with enhanced accuracy and longer operational durations.
  • Medtronic: Provides integrated diabetes management solutions combining CGM and insulin delivery systems.
  • Abbott Laboratories: Sets a benchmark for ease of use and affordability with its FreeStyle Libre system. Other notable players include Nature’s Way Products, GNC Holdings, Banyan Botanicals, Nutramax Laboratories, and more.

Some key companies are:

  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature's Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature's Way Products
  • Abbott
  • Natural Immunogenics

Market Segmentation

By Component:

  • Transmitters and Monitors
  • Sensors
  • Insulin Pumps

By End User:

  • Home Care Diagnostics
  • Hospitals
  • ICU/Critical Care

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Continuous Glucose Monitoring Systems Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Volume and Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. Pestle Analysis
3. Production Output and Trade Statistics, 2019 - 2023
3.1. Global Continuous Glucose Monitoring Systems Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019 - 2023
4.1. Global Average Price Analysis, by Component, US$ Per Unit, 2019 - 2023
4.2. Prominent Factor Affecting Continuous Glucose Monitoring Systems Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit, 2019 - 2023
5. Global Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
5.1. Global Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Transmitters and Monitors
5.1.1.2. Sensors
5.1.1.3. Insulin Pump
5.2. Global Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Home Care Diagnostics
5.2.1.2. Hospitals
5.2.1.3. ICU/Critical Care
5.3. Global Continuous Glucose Monitoring Systems Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. North America
5.3.1.2. Europe
5.3.1.3. Asia Pacific
5.3.1.4. Latin America
5.3.1.5. Middle East & Africa
6. North America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
6.1. North America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Transmitters and Monitors
6.1.1.2. Sensors
6.1.1.3. Insulin Pump
6.2. North America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Home Care Diagnostics
6.2.1.2. Hospitals
6.2.1.3. ICU/Critical Care
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. North America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. U.S. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.1.2. U.S. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.1.3. Canada Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.1.4. Canada Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.2. Bps Analysis/Market Attractiveness Analysis
7. Europe Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
7.1. Europe Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Transmitters and Monitors
7.1.1.2. Sensors
7.1.1.3. Insulin Pump
7.2. Europe Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.2.1. Key Highlights
7.2.1.1. Home Care Diagnostics
7.2.1.2. Hospitals
7.2.1.3. ICU/Critical Care
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Europe Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Germany Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.2. Germany Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.3. U.K. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.4. U.K. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.5. France Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.6. France Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.7. Italy Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.8. Italy Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.9. Turkey Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.10. Turkey Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.11. Russia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.12. Russia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.13. Rest Of Europe Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1.14. Rest Of Europe Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.2. Bps Analysis/Market Attractiveness Analysis
8. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
8.1. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Transmitters and Monitors
8.1.1.2. Sensors
8.1.1.3. Insulin Pump
8.2. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Home Care Diagnostics
8.2.1.2. Hospitals
8.2.1.3. ICU/Critical Care
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. China Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.2. China Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.3. Japan Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.4. Japan Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.5. South Korea Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.6. South Korea Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.7. India Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.8. India Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.9. Southeast Asia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.10. Southeast Asia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.11. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1.12. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
9.1. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.1.1. Key Highlights
9.1.1.1. Transmitters and Monitors
9.1.1.2. Sensors
9.1.1.3. Insulin Pump
9.2. Latin America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.2.1. Key Highlights
9.2.1.1. Home Care Diagnostics
9.2.1.2. Hospitals
9.2.1.3. ICU/Critical Care
9.2.2. BPS Analysis/Market Attractiveness Analysis
9.3. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1. Key Highlights
9.3.1.1. Brazil Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.2. Brazil Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.3. Mexico Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.4. Mexico Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.5. Argentina Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.6. Argentina Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.7. Rest Of Latin America Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1.8. Rest Of Latin America Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.2. Bps Analysis/Market Attractiveness Analysis
10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032
10.1. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.1.1. Key Highlights
10.1.1.1. Transmitters and Monitors
10.1.1.2. Sensors
10.1.1.3. Insulin Pump
10.2. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.2.1. Key Highlights
10.2.1.1. Home Care Diagnostics
10.2.1.2. Hospitals
10.2.1.3. ICU/Critical Care
10.2.2. BPS Analysis/Market Attractiveness Analysis
10.3. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1. Key Highlights
10.3.1.1. GCC Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.2. GCC Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.3. South Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.4. South Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.5. Egypt Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.6. Egypt Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.7. Nigeria Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.8. Nigeria Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.9. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.1.10. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
10.3.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Manufacturer Vs by End User Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Herbalife Nutrition
11.4.1.1. Company Overview
11.4.1.2. Component Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. GNC Holdings
11.4.2.1. Company Overview
11.4.2.2. Component Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. NOW Health
11.4.3.1. Company Overview
11.4.3.2. Component Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Nutramax Laboratories
11.4.4.1. Company Overview
11.4.4.2. Component Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Nature's Bounty
11.4.5.1. Company Overview
11.4.5.2. Component Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Banyan Botanicals
11.4.6.1. Company Overview
11.4.6.2. Component Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Source Naturals
11.4.7.1. Company Overview
11.4.7.2. Component Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Nutramarks Inc
11.4.8.1. Company Overview
11.4.8.2. Component Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Nature's Way Products
11.4.9.1. Company Overview
11.4.9.2. Component Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Abbott
11.4.10.1. Company Overview
11.4.10.2. Component Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Natural Immunogenics
11.4.11.1. Company Overview
11.4.11.2. Component Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms And Abbreviations

Companies Mentioned

  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature's Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature's Way Products
  • Abbott
  • Natural Immunogenics

Methodology

Loading
LOADING...

Related Topics

Related Reports

Continuous Glucose Monitoring Systems Market Report by Component, Demographics, End User, and Region 2024-2032 - Product Image

Continuous Glucose Monitoring Systems Market Report by Component, Demographics, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029 - Product Image

Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029

  • Report
  • 160 Pages
  • Global
From
Continuous Blood Glucose Monitoring Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Continuous Blood Glucose Monitoring Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Global Continuous Glucose Monitoring Market Report by Component, End-User, Regions and Company Analysis 2024-2032 - Product Image

Global Continuous Glucose Monitoring Market Report by Component, End-User, Regions and Company Analysis 2024-2032

  • Report
  • 185 Pages
  • Global
From
United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032) - Product Image

United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)

  • Report
  • 190 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.